BACKGROUND: Experimental and epidemiologic studies have suggested that high calcium intake is associated with decreased colon cancer risk, yet very limited data are available for candidate genes in the calcium-vitamin D pathway and colon cancer risk. To address this, we evaluated whether calcium-sensing receptor (CASR) single-nucleotide polymorphisms are associated with colon cancer risk. We also examined interactions among CASR, calcium, and vitamin D intake and previously genotyped vitamin D-related genes. METHODS: We conducted a large multicenter population-based case-control study of 1,600 cases and 1,949 controls. Seventeen tagging single-nucleotide polymorphisms for CASR were selected from common single-nucleotide polymorphisms (minor allele frequency, >or=5%) based on resequencing data. Haplotypes were estimated and evaluated using HaploStats. RESULTS: We did not observe an association between any CASR genotypes or haplotypes and colon cancer risk overall. However, when stratified by anatomic site, statistically significant associations were seen with risk for proximal colon cancer [rs10934578 TT: odds ratio, 1.35; 95% confidence interval (95% CI), 1.01-1.81; rs12485716 AG/AA: odds ratio, 0.84; 95% CI, 0.71-1.00; rs4678174 CT/CC: odds ratio, 0.83; 95% CI, 0.70-0.98; rs2270916 CC: odds ratio, 0.43; 95% CI, 0.19-0.97]. Concordantly, we observed a suggested association for a CASR haplotype (rs4678174, rs2270916) with risk for proximal colon cancer (global P=0.08). We did not observe any meaningful gene-environment (calcium and vitamin D) or gene-gene (CYP24A1, CYP27B1, and VDR) interactions with CASR genotypes and colon cancer risk. CONCLUSION: Our study does not provide evidence for an overall association between CASR single-nucleotide polymorphisms and colon cancer; however, results suggest a possible role of CASR on proximal colon cancer, and subsite differences are consistent with known calcium biology. Nonetheless, these findings require confirmation.
BACKGROUND: Experimental and epidemiologic studies have suggested that high calcium intake is associated with decreased colon cancer risk, yet very limited data are available for candidate genes in the calcium-vitamin D pathway and colon cancer risk. To address this, we evaluated whether calcium-sensing receptor (CASR) single-nucleotide polymorphisms are associated with colon cancer risk. We also examined interactions among CASR, calcium, and vitamin D intake and previously genotyped vitamin D-related genes. METHODS: We conducted a large multicenter population-based case-control study of 1,600 cases and 1,949 controls. Seventeen tagging single-nucleotide polymorphisms for CASR were selected from common single-nucleotide polymorphisms (minor allele frequency, >or=5%) based on resequencing data. Haplotypes were estimated and evaluated using HaploStats. RESULTS: We did not observe an association between any CASR genotypes or haplotypes and colon cancer risk overall. However, when stratified by anatomic site, statistically significant associations were seen with risk for proximal colon cancer [rs10934578 TT: odds ratio, 1.35; 95% confidence interval (95% CI), 1.01-1.81; rs12485716 AG/AA: odds ratio, 0.84; 95% CI, 0.71-1.00; rs4678174 CT/CC: odds ratio, 0.83; 95% CI, 0.70-0.98; rs2270916 CC: odds ratio, 0.43; 95% CI, 0.19-0.97]. Concordantly, we observed a suggested association for a CASR haplotype (rs4678174, rs2270916) with risk for proximal colon cancer (global P=0.08). We did not observe any meaningful gene-environment (calcium and vitamin D) or gene-gene (CYP24A1, CYP27B1, and VDR) interactions with CASR genotypes and colon cancer risk. CONCLUSION: Our study does not provide evidence for an overall association between CASR single-nucleotide polymorphisms and colon cancer; however, results suggest a possible role of CASR on proximal colon cancer, and subsite differences are consistent with known calcium biology. Nonetheless, these findings require confirmation.
Authors: Maria V Grau; John A Baron; Robert S Sandler; Kristin Wallace; Robert W Haile; Timothy R Church; Gerald J Beck; Robert W Summers; Elizabeth L Barry; Bernard F Cole; Dale C Snover; Richard Rothstein; Jack S Mandel Journal: J Natl Cancer Inst Date: 2007-01-17 Impact factor: 13.506
Authors: Song-Yi Park; Suzanne P Murphy; Lynne R Wilkens; Abraham M Y Nomura; Brian E Henderson; Laurence N Kolonel Journal: Am J Epidemiol Date: 2007-01-10 Impact factor: 4.897
Authors: Jean Wactawski-Wende; Jane Morley Kotchen; Garnet L Anderson; Annlouise R Assaf; Robert L Brunner; Mary Jo O'Sullivan; Karen L Margolis; Judith K Ockene; Lawrence Phillips; Linda Pottern; Ross L Prentice; John Robbins; Thomas E Rohan; Gloria E Sarto; Santosh Sharma; Marcia L Stefanick; Linda Van Horn; Robert B Wallace; Evelyn Whitlock; Tamsen Bassford; Shirley A A Beresford; Henry R Black; Denise E Bonds; Robert G Brzyski; Bette Caan; Rowan T Chlebowski; Barbara Cochrane; Cedric Garland; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan L Hendrix; Barbara V Howard; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Karen C Johnson; Howard Judd; Charles L Kooperberg; Lewis H Kuller; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Norman L Lasser; Cora E Lewis; Marian C Limacher; JoAnn E Manson Journal: N Engl J Med Date: 2006-02-16 Impact factor: 91.245
Authors: Elizabeth A Hibler; Chengcheng Hu; Peter W Jurutka; Maria E Martinez; Elizabeth T Jacobs Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-12-05 Impact factor: 4.254
Authors: Elizabeth T Jacobs; Maria E Martínez; Peter T Campbell; David V Conti; David Duggan; Jane C Figueiredo; Robert W Haile; Elizabeth C LeRoy; Jenny N Poynter; Patricia A Thompson; John A Baron Journal: Carcinogenesis Date: 2010-06-17 Impact factor: 4.944
Authors: Mengmeng Du; Xuehong Zhang; Michael Hoffmeister; Robert E Schoen; John A Baron; Sonja I Berndt; Hermann Brenner; Christopher S Carlson; Graham Casey; Andrew T Chan; Keith R Curtis; David Duggan; W James Gauderman; Edward L Giovannucci; Jian Gong; Tabitha A Harrison; Richard B Hayes; Brian E Henderson; John L Hopper; Li Hsu; Thomas J Hudson; Carolyn M Hutter; Mark A Jenkins; Shuo Jiao; Jonathan M Kocarnik; Laurence N Kolonel; Loic Le Marchand; Yi Lin; Polly A Newcomb; Anja Rudolph; Daniela Seminara; Mark D Thornquist; Cornelia M Ulrich; Emily White; Kana Wu; Brent W Zanke; Peter T Campbell; Martha L Slattery; Ulrike Peters; Jenny Chang-Claude; John D Potter Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-09-05 Impact factor: 4.254
Authors: Laura N Anderson; Michelle Cotterchio; Julia A Knight; Ayelet Borgida; Steven Gallinger; Sean P Cleary Journal: PLoS One Date: 2013-06-24 Impact factor: 3.240